Detection of large scale 3′ deletions in the PMS2 gene amongst Colon-CFR participants: Have we been missing anything?

Mark Clendenning, Michael D. Walsh, Judith Balmana Gelpi, Stephen N Thibodeau, Noralane Morey Lindor, John D. Potter, Polly Newcomb, Loic Lemarchand, Robert Haile, Steve Gallinger, John L. Hopper, Mark A. Jenkins, Christophe Rosty, Joanne P. Young, Daniel D. Buchanan

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Current screening practices have been able to identify PMS2 mutations in 78 % of cases of colorectal cancer from the Colorectal Cancer Family Registry (Colon CFR) which showed solitary loss of the PMS2 protein. However the detection of large-scale deletions in the 3′ end of the PMS2 gene has not been possible due to technical difficulties associated with pseudogene sequences. Here, we utilised a recently described MLPA/long-range PCR-based approach to screen the remaining 22 % (n = 16) of CRC-affected probands for mutations in the 3′ end of the PMS2 gene. No deletions encompassing any or all of exons 12 through 15 were identified; therefore, our results suggest that 3′ deletions in PMS2 are not a frequent occurrence in such families.

Original languageEnglish (US)
Pages (from-to)563-566
Number of pages4
JournalFamilial Cancer
Volume12
Issue number3
DOIs
StatePublished - Sep 2013

Fingerprint

Colorectal Neoplasms
Colon
Mutation
Pseudogenes
Genes
Registries
Exons
Polymerase Chain Reaction
Mismatch Repair Endonuclease PMS2

Keywords

  • Colorectal cancer
  • Germline testing
  • Large deletions
  • Lynch syndrome
  • PMS2
  • Pseudogenes

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Oncology
  • Genetics(clinical)

Cite this

Detection of large scale 3′ deletions in the PMS2 gene amongst Colon-CFR participants : Have we been missing anything? / Clendenning, Mark; Walsh, Michael D.; Gelpi, Judith Balmana; Thibodeau, Stephen N; Lindor, Noralane Morey; Potter, John D.; Newcomb, Polly; Lemarchand, Loic; Haile, Robert; Gallinger, Steve; Hopper, John L.; Jenkins, Mark A.; Rosty, Christophe; Young, Joanne P.; Buchanan, Daniel D.

In: Familial Cancer, Vol. 12, No. 3, 09.2013, p. 563-566.

Research output: Contribution to journalArticle

Clendenning, M, Walsh, MD, Gelpi, JB, Thibodeau, SN, Lindor, NM, Potter, JD, Newcomb, P, Lemarchand, L, Haile, R, Gallinger, S, Hopper, JL, Jenkins, MA, Rosty, C, Young, JP & Buchanan, DD 2013, 'Detection of large scale 3′ deletions in the PMS2 gene amongst Colon-CFR participants: Have we been missing anything?', Familial Cancer, vol. 12, no. 3, pp. 563-566. https://doi.org/10.1007/s10689-012-9597-4
Clendenning, Mark ; Walsh, Michael D. ; Gelpi, Judith Balmana ; Thibodeau, Stephen N ; Lindor, Noralane Morey ; Potter, John D. ; Newcomb, Polly ; Lemarchand, Loic ; Haile, Robert ; Gallinger, Steve ; Hopper, John L. ; Jenkins, Mark A. ; Rosty, Christophe ; Young, Joanne P. ; Buchanan, Daniel D. / Detection of large scale 3′ deletions in the PMS2 gene amongst Colon-CFR participants : Have we been missing anything?. In: Familial Cancer. 2013 ; Vol. 12, No. 3. pp. 563-566.
@article{3a451b7fcdd54907a8d886ca29aea339,
title = "Detection of large scale 3′ deletions in the PMS2 gene amongst Colon-CFR participants: Have we been missing anything?",
abstract = "Current screening practices have been able to identify PMS2 mutations in 78 {\%} of cases of colorectal cancer from the Colorectal Cancer Family Registry (Colon CFR) which showed solitary loss of the PMS2 protein. However the detection of large-scale deletions in the 3′ end of the PMS2 gene has not been possible due to technical difficulties associated with pseudogene sequences. Here, we utilised a recently described MLPA/long-range PCR-based approach to screen the remaining 22 {\%} (n = 16) of CRC-affected probands for mutations in the 3′ end of the PMS2 gene. No deletions encompassing any or all of exons 12 through 15 were identified; therefore, our results suggest that 3′ deletions in PMS2 are not a frequent occurrence in such families.",
keywords = "Colorectal cancer, Germline testing, Large deletions, Lynch syndrome, PMS2, Pseudogenes",
author = "Mark Clendenning and Walsh, {Michael D.} and Gelpi, {Judith Balmana} and Thibodeau, {Stephen N} and Lindor, {Noralane Morey} and Potter, {John D.} and Polly Newcomb and Loic Lemarchand and Robert Haile and Steve Gallinger and Hopper, {John L.} and Jenkins, {Mark A.} and Christophe Rosty and Young, {Joanne P.} and Buchanan, {Daniel D.}",
year = "2013",
month = "9",
doi = "10.1007/s10689-012-9597-4",
language = "English (US)",
volume = "12",
pages = "563--566",
journal = "Familial Cancer",
issn = "1389-9600",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Detection of large scale 3′ deletions in the PMS2 gene amongst Colon-CFR participants

T2 - Have we been missing anything?

AU - Clendenning, Mark

AU - Walsh, Michael D.

AU - Gelpi, Judith Balmana

AU - Thibodeau, Stephen N

AU - Lindor, Noralane Morey

AU - Potter, John D.

AU - Newcomb, Polly

AU - Lemarchand, Loic

AU - Haile, Robert

AU - Gallinger, Steve

AU - Hopper, John L.

AU - Jenkins, Mark A.

AU - Rosty, Christophe

AU - Young, Joanne P.

AU - Buchanan, Daniel D.

PY - 2013/9

Y1 - 2013/9

N2 - Current screening practices have been able to identify PMS2 mutations in 78 % of cases of colorectal cancer from the Colorectal Cancer Family Registry (Colon CFR) which showed solitary loss of the PMS2 protein. However the detection of large-scale deletions in the 3′ end of the PMS2 gene has not been possible due to technical difficulties associated with pseudogene sequences. Here, we utilised a recently described MLPA/long-range PCR-based approach to screen the remaining 22 % (n = 16) of CRC-affected probands for mutations in the 3′ end of the PMS2 gene. No deletions encompassing any or all of exons 12 through 15 were identified; therefore, our results suggest that 3′ deletions in PMS2 are not a frequent occurrence in such families.

AB - Current screening practices have been able to identify PMS2 mutations in 78 % of cases of colorectal cancer from the Colorectal Cancer Family Registry (Colon CFR) which showed solitary loss of the PMS2 protein. However the detection of large-scale deletions in the 3′ end of the PMS2 gene has not been possible due to technical difficulties associated with pseudogene sequences. Here, we utilised a recently described MLPA/long-range PCR-based approach to screen the remaining 22 % (n = 16) of CRC-affected probands for mutations in the 3′ end of the PMS2 gene. No deletions encompassing any or all of exons 12 through 15 were identified; therefore, our results suggest that 3′ deletions in PMS2 are not a frequent occurrence in such families.

KW - Colorectal cancer

KW - Germline testing

KW - Large deletions

KW - Lynch syndrome

KW - PMS2

KW - Pseudogenes

UR - http://www.scopus.com/inward/record.url?scp=84885949060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885949060&partnerID=8YFLogxK

U2 - 10.1007/s10689-012-9597-4

DO - 10.1007/s10689-012-9597-4

M3 - Article

C2 - 23288611

AN - SCOPUS:84885949060

VL - 12

SP - 563

EP - 566

JO - Familial Cancer

JF - Familial Cancer

SN - 1389-9600

IS - 3

ER -